Related posts
Fed jitters pressure marketsThis summary was created by AI, based on 4 opinions in the last 12 months.
Centene (CNC-N) is a provider of healthcare to under-insured families and military personnel in the US. The stock has experienced a breakdown of support levels and is currently testing support from 2023. While technically negative, the company is building cash reserves, retiring debt, and buying back shares, which has potential upside. Experts recommend placing a stop-loss at $72 and predict an upside potential of 16-20%. The stock is currently trading at 16x earnings and under 2x book with a 10% ROE.
About as cheap as it's been in the last 5 years at 1.25x book. FMV is 93% above current price. Earnings and FMV continue to rise. A good buying opportunity.
Centene is a American stock, trading under the symbol CNC-N on the New York Stock Exchange (CNC). It is usually referred to as NYSE:CNC or CNC-N
In the last year, 1 stock analyst published opinions about CNC-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Centene.
Centene was recommended as a Top Pick by on . Read the latest stock experts ratings for Centene.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered Centene In the last year. It is a trending stock that is worth watching.
On 2025-01-14, Centene (CNC-N) stock closed at a price of $63.4.
Support level has definitely been broken. Lower lows, lower highs. All that is negative technically. Looking at a 3-year chart, now testing support from 2023. If that can hold, it's not so bad a picture.